Open AccessHepatic decompensation/serious adverse events in post-liver transplantation recipients on sofosbuvir for recurrent hepatitis C virus
Author(s) -
Neal Patel,
Kian Bichoupan,
Lawrence Ku,
Rachana Yalamanchili,
Alyson Harty,
Donald Gardenier,
Ng Mh,
David Motamed,
Viktoriya Khaitova,
Nancy Bach,
Charissa Chang,
Priya Grewal,
Meena Bansal,
Ritu Agarwal,
Lawrence Liu,
Gene Y. Im,
Jennifer Leong,
Leona KimSchluger,
Joseph A. Odin,
Jawad Ahmad,
Scott L. Friedman,
Douglas T. Dieterich,
Thomas D. Schiano,
Ponni V. Perumalswami,
Andrea D. Branch
Publication year - 2016
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v22.i9.2844
Subject(s) - medicine , sofosbuvir , interquartile range , decompensation , liver transplantation , gastroenterology , adverse effect , cumulative incidence , cirrhosis , hepatitis c , transplantation , regimen , incidence (geometry) , surgery , hepatitis c virus , ribavirin , immunology , virus , physics , optics
To determine the safety profile of new hepatitis C virus (HCV) treatments in liver transplant (LT) recipients with recurrent HCV infection.